Erin Castelloe
- Hepatology top 1%
- Liver Diseases and Immunity 2
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 2
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 2
- Surgery top 10%
-
- Pharmaceutical studies and practices 2
-
- Inflammatory mediators and NSAID effects 1
-
- Immunotoxicology and immune responses 1
-
- Asthma and respiratory diseases 1
-
- Estrogen and related hormone effects 1
- Co-authors
- Д. А. ШапироHanns–Ulrich MarschallLuciano AdoriniMark PruzanskiMark KipnesPaul DillonPaul CloptonSunder Mudaliar
- Cited by
- HepatologyEpidemiologyOncology
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Erin Castelloe
8 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 66
- Hepatology 598
- Epidemiology 883
- Oncology 617
- Endocrinology, Diabetes and Metabolism 228
- Surgery 428
Countries citing papers authored by Erin Castelloe
This map shows the geographic impact of Erin Castelloe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Castelloe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Castelloe more than expected).
Fields of papers citing papers by Erin Castelloe
This network shows the impact of papers produced by Erin Castelloe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Castelloe. The network helps show where Erin Castelloe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Erin Castelloe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2015 | 13 | |
| 3 | Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acidbreakdown → | 2014 | 421 |
| 4 | Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Diseasebreakdown → | 2013 | 767 |
| 5 | 2011 | 47 | |
| 6 | 2011 | 1 | |
| 7 | 2010 | 60 | |
| 8 | 2009 | 15 |
About Erin Castelloe
Erin Castelloe is a scholar working on Hepatology, Small Animals and Pharmacology, having authored 8 papers that have together received 1.3k indexed citations. Recurring topics across this work include Liver Diseases and Immunity (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Pharmaceutical studies and practices (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Inflammatory mediators and NSAID effects (1 paper), Immunotoxicology and immune responses (1 paper), Asthma and respiratory diseases (1 paper) and Estrogen and related hormone effects (1 paper). The work is most often cited by research in Hepatology (598 citations), Epidemiology (883 citations) and Oncology (617 citations). Erin Castelloe has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Д. А. Шапиро, Hanns–Ulrich Marschall, Luciano Adorini, Mark Pruzanski, Mark Kipnes, Paul Dillon, Paul Clopton, Sunder Mudaliar, Linda Morrow and Arun J. Sanyal. Their work appears in journals such as Gastroenterology, Diabetes and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.